Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

MLA

Caroline Robert, et al. “Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1.” Clinical Cancer Research, vol. 29, Dec. 2022, pp. 858–65. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-22-2812.

APA

Caroline Robert, Céleste Lebbé, Thierry Lesimple, Eija Lundström, Valérie Nicolas, Bruno Gavillet, Philippa Crompton, Barouyr Baroudjian, Emilie Routier, & Ferdy J. Lejeune. (2022). Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1. Clinical Cancer Research, 29, 858–865. https://doi.org/10.1158/1078-0432.ccr-22-2812

Chicago

Caroline Robert, Céleste Lebbé, Thierry Lesimple, Eija Lundström, Valérie Nicolas, Bruno Gavillet, Philippa Crompton, Barouyr Baroudjian, Emilie Routier, and Ferdy J. Lejeune. 2022. “Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1.” Clinical Cancer Research 29 (December): 858–65. doi:10.1158/1078-0432.ccr-22-2812.